E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/15/2005 in the Prospect News Biotech Daily and Prospect News PIPE Daily.

New Issue: MedSurge Medical prices C$10 million stock deal

By Sheri Kasprzak

New York, Dec. 15 - MedSurge Medical Products Corp. said it has arranged a private placement for up to C$10 million.

The company plans to sell, through agent Canaccord Capital Corp., 4 million shares at C$2.50 apiece.

Canaccord also has an over-allotment option for up to 600,000 additional shares.

Proceeds will be used for working capital.

Based in Vancouver, B.C., MedSurge is a medical device company.

Issuer:MedSurge Medical Products Corp.
Issue:Stock
Amount:C$10 million
Shares:4 million
Greenshoe:For up to 600,000 shares
Price:C$2.50
Warrants:No
Placement agent:Canaccord Capital Corp.
Pricing date:Dec. 15
Stock price:C$3.59 at close Dec. 15

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.